Equity Research on Forest Laboratories Inc. and Endo Pharmaceuticals Holdings Inc. - Drug Manufacturers - Other Look to New D...
August 05 2011 - 8:35AM
Marketwired
www.stockcall.com/ offers investors comprehensive research on the
Drug Manufacturers - Other industry and has completed analytical
research on
Forest Laboratories Inc. (NYSE:
FRX) and
Endo Pharmaceuticals Holdings Inc.
(NASDAQ: ENDP). Register with us today at www.stockcall.com/ to
have free access to these researches.
The Drug Manufacturers - Other sector, like the rest of the
pharmaceutical world, has a major cause for concern with the coming
patent expirations during the next few years. As many big-revenue
medications come off patent protection and become available for
generic drug makers to copy and sell them, companies will have to
find new ways to make up for lost revenue. Register now at
https://stockcall.com/development/stockcall/page.php?name=register.html
to have free access to our reports on the Drug Manufacturers -
Other industry.
www.stockcall.com/ is an online platform where investors doing
their due-diligence on the Drug Manufacturers - Other industry can
have easy and free access to our analyst research and opinions on
Forest Laboratories Inc. and Endo Pharmaceuticals Holdings Inc.;
investors and shareholders of these companies can simply register
for a complimentary membership at
https://stockcall.com/development/stockcall/page.php?name=register.html.
Forest Laboratories Inc., for example, is optimistic about the
expansion of sales for new drugs to help offset the loss of
Lexapro's patent which expires in March 2012. The company which is
currently embroiled in a conflict with Carl Icahn over positions on
its board has gone as far as making new acquisitions to help
bolster its drug portfolio. Forest Laboratories
Inc. research report is accessible for free by registering
today at www.stockcall.com/FRX050811.pdf.
This trend towards acquiring new drugs is common throughout the
sector. With a new drug from BioSante Pharmaceuticals out to help
improve low libido for women, many companies in the pharmaceutical
world are interested in working a deal with the company. Endo
Pharmaceuticals Holdings Inc. is thought to be one of the companies
interested in the potentially $4 billion per year market.
Endo Pharmaceuticals Holdings Inc. research
report is available for free by signing up now at
www.stockcall.com/ENDP050811.pdf.
Visit www.stockcall.com/ to see how companies in this industry
have grown over the past years and how they are expected to perform
in the future.
About StockCall.com StockCall.com is a
financial website where investors can have easy, precise and
comprehensive research and opinions on stocks making the
headlines.
Contact Person: William T. Knight
stockcall2010@gmail.com
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024